Extension of Warrants

RNS Number : 7595J

Barkby Group PLC (The)

24 December 2020

 

The Barkby Group PLC

("Barkby", the "Group" or the "Company")

Extension of Warrants

The Barkby Group PLC, the diversified business group, announces that its Remuneration Committee have agreed to extend the expiry date of warrants ("Warrants") over ordinary shares of £0.00860675675675676 each in the capital of the Company ("Ordinary Shares") held by Rupert Fraser, Group Managing Director of the Company.

All other aspects of the Warrants are unchanged and are listed below:

Investor Name	Warrants	Exercise Price	Value	Granted	Initial Expiry	New Expiry
Rupert Fraser	1,452,347	8.6p	£124,901.84	30/12/2015	30/12/2020	30/12/2021

Related Party Transaction

The Warrants are held by Rupert Fraser, a Director of the Company. Accordingly, the extension to the expiry date of the Warrants constitutes a related party transaction under Rule 13 of the AIM Rules for Companies. The independent Directors, having consulted with the Company's nominated adviser, finnCap Ltd, consider that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

Enquiries: 

The Barkby Group PLC
Charles Dickson, Executive Chairman Douglas Benzie, Chief Financial Officer
finnCap Ltd (Nomad and Broker)	[phone]
Carl Holmes/Simon Hicks (corporate finance) Tim Redfern/Richard Chambers (ECM)
Camarco (Financial PR)	[phone]

Jennifer Renwick/Jake Thomas

Notes to editors

The Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses within Barkby include; Commercial Property Development, Barkby Hospitality (comprising Barkby Pubs and Workshop Coffee) and Centurian Automotive.

In addition to these businesses, Barkby Life Sciences has invested in VivoPlex, a digital health company aiming to transform Women's Health with precision medicine, and its subsidiary Cambridge Sleep Sciences Ltd has launched, SleepHub™, a device which improves and facilitates natural sleep.

Barkby's strategy is to accelerate and maximise opportunities within its existing businesses as well as continue to source and invest in cash generative, growth businesses with the ability to disrupt.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name:	Rupert Fraser
2.	Reason for the notification
a)	Position/status:	Group Managing Director
b)	Initial notification/Amendment:	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name:	The Barkby Group plc
b)	LEI:	213800X57YXZVILB9E84
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument: Identification code:	Warrants over Ordinary Shares of £0.00860675675675676 GB00BL6TZZ70
b)	Nature of the transaction:	Extension of warrant expiry date from 30 December 2020 to 30 December 2021
c)	Price(s) and volume(s):	Price(s) pence Volume(s) n/a 1,452,347
d)	Aggregated information: · Aggregated volume: · Price:	n/a
e)	Date of the transaction:	24 December 2020
f)	Place of the transaction:	Off market transaction

 

END

 

 

DSHPPGCPPUPUPWW